CAMBRIDGE, Mass. – Common Sensing, partnering with Sanofi and Dexom at the Joslin Diabetes Center in Boston, has kicked off a study of its Gocap insulin pen cap. The Gocap is a Bluetooth-enabled insulin-monitoring device that fits on existing disposable injectors and automatically generates an insulin logbook that can be wirelessly shared with care providers and family. Users can see and share their data over the cloud, and receive reminders and alerts from the accompanying Gocap mobile app. The study will look at the use of disposable insulin pens with the smart cap and associated glycemic control. Both insulin pen use and continuous blood glucose response will be measured automatically around the clock for 125 participants.
You are here: / / Common Sensing kicks off insulin cap study